(Health-NewsWire.Net, October 05, 2018 ) Advent of advanced diagnostic methods such as Interferon-gamma Release Assay (IGRA), serological methods, and nucleic acid testing have resulted in the high usage rate of diagnostics. Moreover, Point of Care (POC) technologies such as antigen assays are also promoting the diagnosis rate of TB.
These advanced methods including POC diagnostics are affordable, accurate, simple, and yield quick results. Furthermore, the rising burden of TB is the primary factor responsible for the lucrative market growth.
Top key players in global Tuberculosis Diagnostics market are - Siemens, F.Hoffmann-La Roche AG, BioMérieux SA, Becton, Dickinson and Company , Alere, Inc., Hain Lifesciences GmBH, Abbott Laboratories, Cepheid, Akkoni, Hologic Corporation, AutoGenomics, iCubate, MARTI TB Diagnostics, Thermo Fisher Scientific, Inc., Sanofi and Qiagen.
Request sample copy at: https://www.reportsweb.com/inquiry&RW00011415577/sample
Global Tuberculosis Diagnostics market is accounted for $2.24 billion in 2016 and is expected to reach $3.30 billion by 2023 growing at a CAGR of 5.7% from 2016 to 2023. Increasing cases of tuberculosis is one of the major factor responsible for high market growth. Furthermore, rising government initiatives, growing requirement of POC in healthcare and increasing geriatric population are some factors that are positively affecting the market. However, lack of awareness among the patients is hindering the market.
Based on test type, diagnostic laboratory method segment dominated the global market as they are cost efficient and easy-to-perform. These tests also include smear microscopy and culture-based tests. The regions with high burden rely on these methodologies owing to their technical and financial inability to incorporate advanced technologies.
Depending on geography, Asia Pacific region is expected to provide profitable growth over the forecast period owing to its huge population base and high burden as well the rapid proliferation of this disease. Countries such as India, China, Afghanistan, and Indonesia have been recognized as the high burden countries. Hence government agencies and WHO have planned initiatives to fortify the force of diagnostic centers including laboratories and the screening networks.
Have any query? Enquire about report at: https://www.reportsweb.com/inquiry&RW00011415577/buying
End Users Covered: -Diagnostic laboratories -Hospitals
Test Types Covered: -Detection of drug resistance -Radiographic method -Diagnostic Laboratory methods -Detection of latent infection -Nucleic acid testing -Phage assay -Mantoux Test -Cytokine detection assay -Other Test Types
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -France -Italy -UK -Spain -Rest of Europe
Get more information at: https://www.reportsweb.com/inquiry&RW00011415577/discount
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|